- Investing.com
Metrics to compare | 1066 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship1066PeersSector | |
|---|---|---|---|---|
P/E Ratio | 8.5x | 23.1x | −0.5x | |
PEG Ratio | −0.39 | −0.24 | 0.00 | |
Price/Book | 0.6x | 1.9x | 2.6x | |
Price / LTM Sales | 1.0x | 2.8x | 3.1x | |
Upside (Analyst Target) | 73.2% | 19.8% | 53.0% | |
Fair Value Upside | Unlock | 14.8% | 6.3% | Unlock |
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People’s Republic of China and internationally. It operates through Medical Device Products, Orthopedic Products, Pharma Packaging Products, Interventional Products, Blood Management Products, and Others segments. The company offers medical device products, including safe infusion, clinical nursing, perioperative, endocrine, urinary, rehabilitation system, and extracorporeal circulation solutions; pharma packaging products comprising prefilled drug delivery system, pharmaceutical packaging consumables, and automatic drug delivery systems; and orthopedic products that include spine, joint, trauma, sports medicine, bone repair material, and spinal endoscope products, as well as orthopedic devices, PRP treatment consumables, and negative pressure drainage consumables. It also provides interventional products, such as tumor, vascular, and nursing interventions, as well as blood management products, including whole blood collection consumables and blood transfusion equipment. In addition, the company manufactures and sells medical PVC granules, plastic packing bags, and carton boxes; manufacture and sale of medical polymer materials and products; injection puncture instruments; computer technical services; and X-ray based irradiation machines. Further, it provides finance leasing, factoring, and consulting services. The company was founded in 1988 and is based in Weihai, the People’s Republic of China.